Bausch Health Companies Inc. (NYSE:BHC) has a beta value of 1.07 and has seen 3,619,030 shares traded in the recent trading session. The company, currently valued at $6.06 Billion, closed the recent trade at $17.06 per share which meant it gained $0.8 on the day or 4.92% during that session. The BHC stock price is -87.4% off its 52-week high price of $31.97 and 34.64% above the 52-week low of $11.15. If we look at the company’s 10-day average daily trading volume, we find that it stood at 3.37 Million shares traded. The 3-month trading volume is 4.18 Million shares.
The consensus among analysts is that Bausch Health Companies Inc. (BHC) is an Overweight stock at the moment, with a recommendation rating of 2.2. None of the analysts rate the stock as a Sell, while 1 rate it as Overweight. 5 out of 17 have rated it as a Hold, with 10 advising it as a Buy. 1 have rated the stock as Underweight. The expected earnings per share for the stock is $0.96.
Bausch Health Companies Inc. (NYSE:BHC) trade information
Sporting 4.92% in the green today, the stock has traded in the green over the last five days, with the highest price hit on Wednesday, Sep 16 when the BHC stock price touched $16.82- or saw a rise of 0.21%. Year-to-date, Bausch Health Companies Inc. shares have moved -43.92%, while the 5-day performance has seen it change 3.84%. Over the past 30 days, the shares of Bausch Health Companies Inc. (NYSE:BHC) have changed -4%. Short interest in the company has seen 17.85 Million shares shorted with days to cover at 4.27.
Wall Street analysts have a consensus price target for the stock at $26.75, which means that the shares’ value could jump 56.8% from current levels. The projected low price target is $16 while the price target rests at a high of $50. In that case, then, we find that the current price level is +193.08% off the targeted high while a plunge would see the stock lose -6.21% from current levels.
Bausch Health Companies Inc. (BHC) estimates and forecasts
Figures show that Bausch Health Companies Inc. shares have underperformed across the wider relevant industry. The company’s shares have gained +10.54% over the past 6 months, with this year growth rate of -18.28%, compared to -11.7% for the industry. Other than that, the company has, however, lowered its growth outlook for the 2020 fiscal year revenue. Growth estimates for the current quarter are -19.3% and 13.4% for the next quarter. Revenue growth from the last financial year stood is estimated to be -8.7%.
12 analysts offering their estimates for the company have set an average revenue estimate of $1.98 Billion for the current quarter. 12 have an estimated revenue figure of $2.19 Billion for the next quarter concluding in December 01, 2020. Year-ago sales stood $2.21 Billion and $2.22 Billion respectively for this quarter and the next, and analysts expect sales will grow by -10.4% for the current quarter and -1.4% for the next.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -31.7% over the past 5 years. Earnings growth for 2020 is a modest +57% while over the next 5 years, the company’s earnings are expected to increase by 2%.
Bausch Health Companies Inc. (NYSE:BHC)’s Major holders
Insiders own 0.55% of the company shares, while shares held by institutions stand at 66.95% with a share float percentage of 67.32%. Investors are also buoyed by the number of investors in a company, with Bausch Health Companies Inc. having a total of 519 institutions that hold shares in the company. The top two institutional holders are Paulson & Company, Inc. with over 25.84 Million shares worth more than $472.6 Million. As of June 29, 2020, Paulson & Company, Inc. held 7.28% of shares outstanding.
The other major institutional holder is FIL LTD, with the holding of over 18.35 Million shares as of June 29, 2020. The firm’s total holdings are worth over $335.63 Million and represent 5.17% of shares outstanding.
Also the top two Mutual Funds that are holding company’s shares are Vanguard International Stock Index-Total Intl Stock Indx and Price (T.Rowe) Value Fund. As of April 29, 2020, the former fund manager holds about 1.7% shares in the company for having 6031282 shares of worth $109.29 Million while later fund manager owns 4.46 Million shares of worth $81.66 Million as of June 29, 2020, which makes it owner of about 1.26% of company’s outstanding stock.